Health product recall

NUCALA PRE-FILLED AUTOINJECTOR(2021-07-09)

Starting date:
July 9, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76037

Last updated:
2021-07-15

Summary

  • Product:
    NUCALA PRE-FILLED AUTOINJECTOR

Reason

Presence of foreign matter in the affected lot.

Depth of distribution

Retailers, Wholesalers

Affected products

NUCALA PRE-FILLED AUTOINJECTOR

DIN, NPN, DIN-HIM

DIN 02492989

Dosage form

Solution

Strength

MEPOLIZUMAB 100 MG / ML

Lot or serial number

JP3E, A73A

Companies

Recalling Firm

GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4

Marketing Authorization Holder

GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4